01-01_Aflibercept+FOLFIRI　PDF 02-01_BEACON(2剤併用)　PDF 02-03_BEACON(3剤併用)　PDF 02-05_Bev+FOLFOXIRI　PDF 02-06_Bev5+FOLFIRI　PDF 02-07_Bev5+IRIS　PDF 02-08_Bev5+mFOLFOX6　PDF 03-01_CBDCA+ETP(大腸神経内分泌癌)　PDF 03-02_大腸内分泌細胞癌CDDP60+CPT-11(60)　PDF 03-04_CET　PDF 03-06_CET+biweekly CPT-11　PDF 03-08_CET+CPT-11(q2w)　PDF 03-09_CET+FOLFIRI(q2w)　PDF 03-09_CET+FOLFIRI　PDF 03-11_CET+FOLFIRI(q2w)　PDF 03-12_CET+mFOLFOX6　PDF 03-14_CET+mFOLFOX6(q2w)　PDF 03-15_CET+weekly CPT-11　PDF 03-17_CPT-11　PDF 06-01_FOLFIRI　PDF 09-01_ＩＲＩＳ　PDF 13-01_mFOLFOX6　PDF 13-02_MSI-High Pembrolizumab(大腸癌)　PDF 13-04_mXELIRI＋Bev　PDF 16-01_ﾊﾟﾆﾂﾑﾏﾌﾞ　PDF 16-02_ﾊﾟﾆﾂﾑﾏﾌﾞ+CPT-11 biweekly　PDF 16-03_ﾊﾟﾆﾂﾑﾏﾌﾞ+FOLFIRI　PDF 16-04_ﾊﾟﾆﾂﾑﾏﾌﾞ+IRIS　PDF 16-05_ﾊﾟﾆﾂﾑﾏﾌﾞ+mFOLFOX6　PDF 16-06_ﾊﾟﾆﾂﾑﾏﾌﾞ+XELOX　PDF 16-07_Pertuzumab+HER　PDF 18-01_Ramu+FOLFIRI　PDF 19-01_S-1＋CET　PDF 19-03_SIRB　PDF 19-04_SOX　PDF 19-05_SOX+Bev　PDF 19-06_SOX＋CET weekly　PDF 19-08_STZ(daily)　PDF 19-09_STZ(weekly)　PDF 19-10_STZ+5-FU　PDF 20-01_TAS-102+Bev　PDF 20-02_TMB-High Pembrolizumab(大腸癌)　PDF 20-04_TMB-High Pembrolizumab(肛門癌)　PDF 24-01_XELIRI＋CET weekly　PDF 24-03_XELODA＋Beva　PDF 24-04_XELOX　PDF 24-05_XELOX＋CET weekly　PDF 24-07_XELOX＋ｱﾊﾞｽﾁﾝ　PDF 24-08_XELOX(adjuvant)　PDF